Crowdonomics
WatchlistPortfolio
Remedy Processors LLC

Reg CF · Convertible Note · Nov 2020

ClosedReached targetReg CFConvertible Note
via MICROVENTURE MARKETPLACE INC. · last checked Aug 17, 2026
Raised
$152.2K / $250K max
61% of ceiling
Investors
—
—
Valuation
—
—

Financials disclosed in this offering

FY2018–FY2019 · hover for source
$0
FY2018
$20K
−$288K
FY2019
RevenueNet income
Metric
FY2018 reviewed*
FY2019 reviewed*
Income statement
Revenue
$0
$20,275
Cost of goods sold
$0
$0
Gross margin
—
100%
Net income
$0
-$287,896
Taxes paid
$0
$6,276
Balance sheet
Cash
$0
$27,978
Accounts receivable
$0
$0
Total assets
$0
$152,698
Short-term debt
$0
$80,268
Long-term debt
$0
$0
Total liabilities
$0
$80,268
Other
Headcount
—
10

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

3 amendments
  1. Apr 15, 2021
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  2. Feb 8, 2021
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗
  3. Dec 16, 2020
    Terms not yet extracted from this filing
    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

No priced terms — this is a revenue-share or unpriced offering.

Offering details

Target$25,000
Max$250,000
Min investment—
OpenedNov 19, 2020
DeadlineJun 21, 2021
ClosedApr 19, 2021
Days active151

Links & provenance

SEC filing
Source: SEC EDGAR
0001823421-20-000001
Last synced Aug 17, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.